Bon Natural Life (BON)
NASDAQ:BON
Want to see BON full AI Analyst Report?
BON Stock Chart & Stats
$1.70
-$0.04(-2.34%)
At close: 4:00 PM EST
$1.70
-$0.04(-2.34%)
Day’s Range― - ―
52-Week Range$1.13 - $3.40
Previous Close$1.67
Volume111.86K
Average Volume (3M)2.24M
Market Cap
$10.40M
Enterprise Value$13.48M
Total Cash (Recent Filing)$6.27M
Total Debt (Recent Filing)$12.32M
Price to Earnings (P/E)―
Beta1.68
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,086,971
10 Day Avg. Volume115,576
30 Day Avg. Volume2,242,045
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.09
Price to Sales (P/S)0.29
P/FCF Ratio-1.27
Enterprise Value/Market Cap1.30
Enterprise Value/Revenue0.72
Enterprise Value/Gross Profit3.48
Enterprise Value/Ebitda614.95
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance-sheet ResilienceThe company maintains relatively low leverage (debt-to-equity ~0.21) and materially higher equity versus prior years, providing a multi-year balance-sheet buffer. That capital base supports liquidity and borrowing flexibility while operations recover, reducing risk of near-term solvency pressure.
Proven Prior ProfitabilityBon Natural Life produced consistent profits across 2020–2023, indicating its product mix and go-to-market can generate durable margins. This historical track record implies management can restore margins and scale revenue if cost trends and demand normalize, supporting medium-term recovery potential.
Strengthened R&D LeadershipA formally appointed CTO with deep technical credentials and a three-year contract represents a structural uplift in R&D capability. Enhanced in-house science leadership can drive product innovation, reformulation, and new product pipeline development that supports sustainable differentiation in natural health products.
Bears Say
Persistent Negative Free Cash FlowRecurring negative free cash flow and intermittently negative operating cash flow weaken internal funding of operations and reinvestment. Over several quarters this erodes liquidity, increases reliance on external financing, and constrains strategic options unless operating cash generation sustainably rebounds.
Revenue Decline And Margin CompressionSteep revenue decline and material margin compression point to weakening pricing power or cost pressures. Such structural erosion of top-line and gross margins undermines profitability sustainability and makes margin recovery necessary for long-term viability, not just short-term fixes.
Rising Debt And Weak ReturnsIncreasing debt alongside negative returns on equity signals deteriorating capital efficiency. Higher fixed obligations amplify risk if profits do not return, limiting capacity to invest in growth or absorb shocks and potentially increasing cost of capital over the medium term.
Bon Natural Life News
BON FAQ
What was Bon Natural Life’s price range in the past 12 months?
Bon Natural Life lowest stock price was $1.13 and its highest was $3.40 in the past 12 months.
What is Bon Natural Life’s market cap?
Bon Natural Life’s market cap is $10.40M.
When is Bon Natural Life’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bon Natural Life’s earnings last quarter?
Currently, no data Available
Is Bon Natural Life overvalued?
According to Wall Street analysts Bon Natural Life’s price is currently Overvalued.
Does Bon Natural Life pay dividends?
Bon Natural Life does not currently pay dividends.
What is Bon Natural Life’s EPS estimate?
Bon Natural Life’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bon Natural Life have?
Bon Natural Life has 6,086,971 shares outstanding.
What happened to Bon Natural Life’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bon Natural Life?
Currently, no hedge funds are holding shares in BON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bon Natural Life
Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts. Its operations span the People's Republic of China and international markets. The company's diverse product range includes components for personal care items, such as plant-derived aromatic compounds supplied to manufacturers of perfumes and fragrances. It also develops natural health products, featuring powdered beverages and biologically active food ingredients primarily intended for use as food additives, as well as a variety of nutritional supplements. These offerings are predominantly utilized by industrial clients in the functional food, personal care, cosmetic, and pharmaceutical sectors. Founded in 2006, Bon Natural Life Limited's main office is located in Grand Cayman, Cayman Islands.
Technical Analysis
Planet Green Holdings
―
Natural Alternatives International
―
Farmmi
―
Laird Superfood
―
Healthy Choice Wellness Corp. Class A
―